Validation of the functional assessment of multiple sclerosis quality of life instrument

被引:319
作者
Cella, DF
Dineen, K
Arnason, B
Reder, A
Webster, KA
Karabatsos, G
Chang, C
Lloyd, S
Mo, F
Stewart, J
Stefoski, D
机构
[1] RUSH PRESBYTERIAN ST LUKES MED CTR, CHICAGO, IL 60612 USA
[2] UNIV CHICAGO, SCH MED, CHICAGO, IL 60637 USA
关键词
D O I
10.1212/WNL.47.1.129
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Based on scientific literature and interviews with clinicians and patients, we developed a quality of life instrument for use with people with MS called the Functional Assessment of Multiple Sclerosis (FAMS). The initial item pool consisted of 88 questions: 28 from the general version of the Functional Assessment of Cancer Therapy quality of life instrument, plus 60 generated by patients, providers, and literature review. The validation samples comprised a mail survey cohort (N = 377) and a clinical cohort (N = 56). Both cohorts provided evidence for internal consistency of the derived subscales, test-retest reliability, content validity, concurrent validity, and construct validity. Principal components and Rasch measurement model analyses were applied sequentially to survey sample data, reducing test length to 44 questions, divided into six subscales: mobility, symptoms, emotional well-being (depression), general contentment, thinking/fatigue, and family/social well-being. Fifteen initially rejected questions were added back as miscellaneous (unscored) questions for their potential clinical and empirical value. The mobility subscale was strongly predictive of the Kurtzke Extended Disability Status Scale and the Scripps Neurologic Rating Scales. The other five subscales were not, indicating they measure aspects of patient quality of life not captured by the neurologic exam. The final 59-item English language instrument (FAMS version 2) is available for inclusion in clinical trials and clinical practice.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 25 条
  • [1] RATING FORMULATION FOR ORDERED RESPONSE CATEGORIES
    ANDRICH, D
    [J]. PSYCHOMETRIKA, 1978, 43 (04) : 561 - 573
  • [2] [Anonymous], 1980, PROBABILISTIC MODELS
  • [3] THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE
    CELLA, DF
    TULSKY, DS
    GRAY, G
    SARAFIAN, B
    LINN, E
    BONOMI, A
    SILBERMAN, M
    YELLEN, SB
    WINICOUR, P
    BRANNON, J
    ECKBERG, K
    LLOYD, S
    PURL, S
    BLENDOWSKI, C
    GOODMAN, M
    BARNICLE, M
    STEWART, I
    MCHALE, M
    BONOMI, P
    KAPLAN, E
    TAYLOR, S
    THOMAS, CR
    HARRIS, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 570 - 579
  • [4] EMOTIONAL IMPACT OF MULTIPLE-SCLEROSIS - RECENT FINDINGS AND SUGGESTIONS FOR FUTURE-RESEARCH
    DEVINS, GM
    SELAND, TP
    [J]. PSYCHOLOGICAL BULLETIN, 1987, 101 (03) : 363 - 375
  • [5] FATIGUE IN MULTIPLE-SCLEROSIS
    KRUPP, LB
    ALVAREZ, LA
    LAROCCA, NG
    SCHEINBERG, LC
    [J]. ARCHIVES OF NEUROLOGY, 1988, 45 (04) : 435 - 437
  • [6] KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
  • [7] LECTENBERG R, 1988, MULTIPLE SCLEROSIS F
  • [8] A RASCH MODEL FOR PARTIAL CREDIT SCORING
    MASTERS, GN
    [J]. PSYCHOMETRIKA, 1982, 47 (02) : 149 - 174
  • [9] SOCIAL RELATIONSHIPS, KNOWLEDGE AND ADJUSTMENT TO MULTIPLE-SCLEROSIS
    MAYBURY, CP
    BREWIN, CR
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1984, 47 (04) : 372 - 376
  • [10] Miller DM, 1994, J NEUROREHAB, V8, P145